Henry Childs

The paper introduces CCK*, a suite of algorithms for de novo design of L- and D-peptides, integrating data-driven and physics-based methods to expand design space across chiral spaces.

This paper evaluates AlphaFold 3's ability to predict D-peptide chirality, fold, and binding pose in heterochiral complexes and finds it performs poorly, with a high chirality violation rate.

DexDesign is a new OSPREY-based algorithm for designing D-peptide inhibitors targeting PDZ domains, generating peptides predicted to bind tighter than endogenous ligands.